Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Perkinelmer (PKI)

Perkinelmer (PKI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,924,845
  • Shares Outstanding, K 111,304
  • Annual Sales, $ 2,884 M
  • Annual Income, $ 227,560 K
  • 60-Month Beta 1.31
  • Price/Sales 2.79
  • Price/Cash Flow 11.53
  • Price/Book 2.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.54
  • Number of Estimates 7
  • High Estimate 0.71
  • Low Estimate 0.20
  • Prior Year 0.69
  • Growth Rate Est. (year over year) -21.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.91 +19.87%
on 03/23/20
80.32 -6.11%
on 03/26/20
-8.10 (-9.70%)
since 03/06/20
3-Month
62.91 +19.87%
on 03/23/20
102.46 -26.40%
on 01/15/20
-22.59 (-23.05%)
since 01/06/20
52-Week
62.91 +19.87%
on 03/23/20
103.00 -26.79%
on 04/09/19
-23.59 (-23.83%)
since 04/05/19

Most Recent Stories

More News
BD Gets EUA for New Test to Combat the Coronavirus Crisis

BD (BDX) partners with BioGX to introduce a new diagnostic test to help hospitals boost the capacity of quick, on-site testing of COVID-19.

BDX : 237.69 (+4.83%)
PKI : 75.41 (+5.91%)
COO : 296.68 (+6.08%)
ABT : 82.73 (+4.13%)
BD Launches New Test to Help Combat the Coronavirus Outbreak

BD (BDX), along with BioMedomics, launches a new point-of-care test to help fight the coronavirus outbreak.

BDX : 237.69 (+4.83%)
PKI : 75.41 (+5.91%)
COO : 296.68 (+6.08%)
HSIC : 47.14 (+1.70%)
Outlook on the Global Non-Invasive Prenatal Testing Market to 2027 - Featuring PerkinElmer, Natera & F. Hoffman La Roche Among Others - ResearchAndMarkets.com

The "Global Non-Invasive Prenatal Testing Market Demand Analysis & Opportunity Evaluation, 2019-2027" report has been added to ResearchAndMarkets.com's offering.

PKI : 75.41 (+5.91%)
FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus (Revised)

These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.

DGX : 78.69 (+7.29%)
HOLX : 35.86 (+9.26%)
PKI : 75.41 (+5.91%)
ABT : 82.73 (+4.13%)
TMO : 304.00 (+7.72%)
Image Analysis Software Market With Robust CAGR in Forecast Period 2020 to 2026

In 2019, the global Image Analysis Software market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2020-2026.

PKI : 75.41 (+5.91%)
FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus

These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.

DGX : 78.69 (+7.29%)
HOLX : 35.86 (+9.26%)
PKI : 75.41 (+5.91%)
ABT : 82.73 (+4.13%)
TMO : 304.00 (+7.72%)
Here's Why You Should Hold On to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) expects to witness foreign exchange headwinds in 2020.

SYK : 165.66 (+11.88%)
ARAY : 1.9400 (+12.14%)
PKI : 75.41 (+5.91%)
COO : 296.68 (+6.08%)
PerkinElmer (PKI) Receives EUA for Coronavirus Detection Test

PerkinElmer (PKI) introduces test for the detection of coronavirus after it receives EUA for the same.

BDX : 237.69 (+4.83%)
PKI : 75.41 (+5.91%)
COO : 296.68 (+6.08%)
ABT : 82.73 (+4.13%)
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA)...

PKI : 75.41 (+5.91%)
PKI May 15th Options Begin Trading

Investors in PerkinElmer, Inc. saw new options begin trading today, for the May 15th expiration.

PKI : 75.41 (+5.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade PKI with:

Business Summary

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Their dedicated team of whole employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical...

See More

Key Turning Points

2nd Resistance Point 78.06
1st Resistance Point 76.74
Last Price 75.41
1st Support Level 73.56
2nd Support Level 71.70

See More

52-Week High 103.00
Fibonacci 61.8% 87.69
Fibonacci 50% 82.96
Fibonacci 38.2% 78.22
Last Price 75.41
52-Week Low 62.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar